Pyropia yezoensis-derived porphyran attenuates acute and chronic colitis by suppressing dendritic cells

Int J Biol Macromol. 2023 Mar 15:231:123148. doi: 10.1016/j.ijbiomac.2023.123148. Epub 2023 Jan 11.

Abstract

Porphyran is known to inhibit immune cell function. Previously, porphyran was shown to prevent lipopolysaccharide-induced sepsis in mice. However, studies on the inhibitory effects of porphyran during colitis are currently lacking. In this study, we evaluated the effects of Pyropia yezoensis-derived porphyran on dextran sodium sulfate (DSS)-induced acute and chronic colitis. The oral or intraperitoneal administration of porphyran inhibited the progression of DSS-induced colitis in mice, with the former also preventing immune cell infiltration in the colon. The levels of intracellular interferon-γ and interleukin-17 in T cells decreased when porphyran was administered orally. Porphyran inhibited T cell activation by suppressing dendritic cells (DCs) and macrophages. Porphyran prevented pathogen-associated molecular pattern and damage-associated molecular pattern-dependent DC and macrophage activation. Finally, porphyran attenuated chronic colitis caused via the long-term administration of DSS. These findings indicate that the oral administration of porphyran can inhibit DSS-induced colitis by suppressing DC and macrophage activation.

Keywords: Autoimmune disease; Colitis; Dendritic cells; Helper T cells; Porphyran.

MeSH terms

  • Animals
  • Colitis* / chemically induced
  • Colon
  • Dendritic Cells
  • Dextran Sulfate / adverse effects
  • Disease Models, Animal
  • Mice
  • Mice, Inbred C57BL
  • Rhodophyta*
  • Sepharose / pharmacology

Substances

  • porphyran
  • Sepharose
  • Dextran Sulfate